Evolution of syphilis incidence in Sibiu county (Romania) over a period of 10 years (2009‑2018)

Iancu,Gabriela Mariana; Rotaru,Maria

doi:10.3892/etm.2021.10235

Evolution of syphilis incidence in Sibiu county (Romania) over a period of 10 years (2009‑2018)

Authors:
- Gabriela Mariana Iancu
- Maria Rotaru
View Affiliations

Affiliations: Department of Dermatology, Lucian Blaga University of Sibiu, Faculty of Medicine, 550169 Sibiu, Romania
Published online on: May 26, 2021 https://doi.org/10.3892/etm.2021.10235
Article Number: 803

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Syphilis is the most common sexually transmitted disease that mainly affects socially active people, with a fluctuating worldwide incidence over the years. A retrospective study was conducted over a period of 10 years (2009‑2018) that included 396 patients with syphilis diagnosed and monitored by Sibiu County Emergency Clinical Hospital, Romania. During this period (2009‑2018), we observed a decrease in the new cases of syphilis by 35.90%, and the average syphilis incidence was 9.90 new cases per 100,000 inhabitants. Syphilis was diagnosed more frequently in men with an average age of 35.39 years, from urban areas, with and educational level of grades 9‑12, unmarried, workers, or without occupation. Out of the 396 patients with syphilis, about 6% were HIV coinfected. Over half of the HIV coinfected cases were declared MSM (men who have sex with men), and 40% of these cases were registered in 2018. The most common clinical stage of syphilis was the latent form (67.93%). Regarding the syphilis treatment regimen, we noted the transition from the classic regimen with benzathine‑penicillin G (100% in 2009) to alternative therapies (mainly with cephalosporins) in 2018 (56.86%). Our findings showed that in the last 10 years in our county, the incidence of syphilis had a downward trend, but with an increase in syphilis‑HIV co‑infection and neurosyphilis cases.

View Figures

View References

1	Danescu SA, Szolga B, Georgiu C, Surcel A and Senila SC: Unusual manifestations of secondary syphilis: Case presentations. Acta Dermatovenerol Croat. 26:186–188. 2018.PubMed/NCBI
2	Rotaru M, Maniu H, Lisandru M and Iancu G: Diagnostic difficulties in secondary syphilis associated with psoriasis vulgaris-clinical case. Dermatovenerologia. 61:249–256. 2016.
3	Parker SR, Correnti C, Sikora K and Parker DC: Seronegative syphilis: Another case for the great imitator. Int J Infect Dis. 18:104–105. 2014.PubMed/NCBI View Article : Google Scholar
4	Oanta A and Irimie M: Syphilitic balanitis of follmann. Int J Dermatol. 53:830–831. 2014.PubMed/NCBI View Article : Google Scholar
5	Etheridge T, Bowen RC, Raven M, Snow KB, Urban AW and Chang JS: Ocular syphilis: Clinical manifestations and treatment course. WMJ. 118:191–195. 2019.PubMed/NCBI
6	Kojima N and Klausner JD: Un update on the global epidemiology of syphilis. Curr Epidemiol Rep. 5:24–38. 2018.PubMed/NCBI View Article : Google Scholar
7	World Health Organization: Sexually Transmitted Infections (STIs). https://www.who.int/publications/data/gho/data/themes/sexually-transmitted-infections. Accessed June 16, 2020.
8	Grad AI, Senila SC, Cosgarea R, Tataru AD, Vesa SC, Vica ML, Matei HV and Ungureanu L: Sexual behaviors, attitudes, and knowledge about sexually transmitted infections: A cross-sectional study in Romania. Acta Dermatovenerol Croat. 26:25–32. 2018.PubMed/NCBI
9	Centers for Disease Control and Prevention: Syphilis. https://www.cdc.gov/std/stats17/syphilis.htm. Accessed July 2, 2020.
10	Karp G, Schlaeffer F, Jotkowitz A and Riesenberg K: Syphilis and HIV co-infection. Eur J Intern Med. 20:9–13. 2009.PubMed/NCBI View Article : Google Scholar
11	International Union Against Sexually Transmitted Infections 2019 European Congress: Abstract Book. www.conference-expert.eu/en/iusti2019/en/abstract-book/1. Accessed June 2, 2020.
12	European Centre for Disease Prevention and Control: Syphilis and congenital syphilis in Europe-A review of epidemiological trends (2007-2018) and options for response. https://www.ecdc.europa.eu/sites/default/files/documents/syphilis-and-congenital-syphilis-in-Europe.pdf. Accessed February 18, 2021.
13	European Centre for Disease Prevention and Control: Syphilis notifications in the EU/EEA up by 70% since 2010. https://www.ecdc.europa.eu/en/news-events/syphilis-notifications-eueea-70-2010. Accessed October 11, 2020.
14	Chen ZQ, Zhang GC, Gong XD, Lin C, Gao X, Liang GJ, Yue XL, Chen XS and Cohen MS: Syphilis in China: Results of a national surveillance programme. Lancet. 369:132–138. 2007.PubMed/NCBI View Article : Google Scholar
15	Singh AE and Romanowski B: Syphilis: Review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev. 12:187–209. 1999.PubMed/NCBI View Article : Google Scholar
16	Thomas JC, Kulik AL and Schoenbach VJ: Syphilis in the South: Rural rates surpass urban rates in North Carolina. Am J Public Health. 85:1119–1122. 1995.PubMed/NCBI View Article : Google Scholar
17	European Centre for Disease Prevention and Control: Syphilis and congenital syphilis in Europe-A review of epidemiological trends (2007-2018) and options for response. https://www.ecdc.europa.eu/en/publications-data/syphilis-and-congenital-syphilis-europe-review-epidemiological-trends-2007-2018. Accessed June 28, 2020.
18	Brown DL and Frank JE: Diagnosis and management of syphilis. Am Fam Physician. 68:283–290. 2003.PubMed/NCBI
19	Cao Y, Su X, Wang Q, Xue H, Zhu X, Zhang C, Jiang J, Qi S, Gong X, Zhu X, et al: A multicenter study evaluating Ceftriaxone and Benzathine Penicillin G as treatment agents for early syphilis in Jiangsu, China. Clin Infect Dis. 65:1683–1688. 2017.PubMed/NCBI View Article : Google Scholar